Abbott Laboratories Inc. has agreed to acquire St. Jude Medical Inc. for $25 billion, creating a third player – along with Boston Scientific Corp. and Medtronic PLC – that competes in all major sectors of the cardiovascular device business.
During the April 28 earnings call announcing the definitive merger agreement, Abbott Chairman and CEO Miles White emphasized the firms'...